MAPT and Alzheimer disease: Compared with widely used transgenic 3xTg-AD animals, the AD model of ICV-STZ mouse shows the dysfunction of energy homeostasis and multiple other effects of SAD abnormalities which are not caused by overexpression of transgenes of amyloid-β precursor protein (APP), presenilin-1 (PS1), and tau [11].